Vesair Continued Access Trial
NCT03082118 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 7
Last updated 2019-07-05
Summary
Single arm study of the Vesair Balloon in postmenopausal women.
Conditions
- Stress Urinary Incontinence
Interventions
- DEVICE
-
Vesair Bladder Control System
Intravesical balloon
Sponsors & Collaborators
-
Solace Therapeutics, Inc.
lead INDUSTRY
Study Design
- Allocation
- NA
- Purpose
- TREATMENT
- Masking
- NONE
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 18 Years
- Sex
- FEMALE
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2017-03-09
- Primary Completion
- 2019-01-15
- Completion
- 2019-01-15
- FDA Device
- Yes
Countries
- United States
Study Locations
More Related Trials
-
Study of VESIcare® In Overactive Bladder (OAB) Subjects to Evaluate Symptom Bother and Health Related Quality of Life
NCT00573508 ·Status: COMPLETED ·Phase: PHASE4
-
A Multicenter VESIcare® Efficacy and Safety Study for the Treatment of Urgency Associated With Overactive Bladder (OAB)
NCT00454896 ·Status: COMPLETED ·Phase: PHASE3
-
A Double-Blind, Paralleled Study Comparing Efficacy/Safety of Solifenacin to Tolterodine in Overactive Bladder Patients
NCT00368706 ·Status: COMPLETED ·Phase: PHASE3
-
Long-Term Open-Label Extension Trial for Subjects Completing the Phase 3 Trial of Fesoterodine (SP583) for the Treatment of Overactive Bladder Syndrome
NCT00220402 ·Status: COMPLETED ·Phase: PHASE3
-
Fesoterodine Flexible Dose Study
NCT00536484 ·Status: COMPLETED ·Phase: PHASE3
-
Long-Term Open-Label Extension Trial for Subjects Completing the Phase 3 Trial of Fesoterodine (SP584) for the Treatment of Overactive Bladder Syndrome
NCT00220376 ·Status: COMPLETED ·Phase: PHASE3
-
Web-based Methodology Trial to Evaluate the Efficacy and Safety of Tolterodine ER in Subjects With Overactive Bladder
NCT01302938 ·Status: TERMINATED ·Phase: PHASE4
-
Trial to Investigate the Efficacy, Tolerability and Safety of Fesoterodine Sustained Release in Subjects With Overactive Bladder Syndrome
NCT00138723 ·Status: COMPLETED ·Phase: PHASE3
-
A Study Of Efficacy And Safety Of Fesoterodine In Vulnerable Elderly Subjects With Overactive Bladder
NCT00928070 ·Status: COMPLETED ·Phase: PHASE4
-
Study to Compare the Safety and Efficacy of Solifenacin With Oxybutynin for the Treatment of Overactive Bladder (VECTOR)
NCT00431041 ·Status: COMPLETED ·Phase: PHASE4
-
A Study to Evaluate Once Daily Low Dose and High Dose Solabegron or Placebo Given for 12 Weeks to Treat Women With Symptoms of Overactive Bladder: Sudden Urge to Urinate, Frequent Urination Associated With Wetting Episodes (VEL-2001)
NCT03594058 ·Status: COMPLETED ·Phase: PHASE2
-
Bringing Simple Urge Incontinence Diagnosis & Treatment to Providers (BRIDGES)
NCT00862745 ·Status: COMPLETED ·Phase: PHASE4
-
Solifenacin Succinate (VESIcare) for the Treatment of Overactive Bladder in Parkinson's Disease
NCT01018264 ·Status: COMPLETED ·Phase: PHASE4
-
A Study to Evaluate the Efficacy of Tolterodine on Specific Symptoms in Adult Patients With Overactive Bladder.
NCT00645281 ·Status: COMPLETED ·Phase: PHASE4
-
Effect Of Detrol LA With Behavioral Intervention In Overactive Bladder Subjects Dissatisfied With Recent OAB Medication.
NCT00230789 ·Status: COMPLETED ·Phase: PHASE4
-
Evaluate Efficacy and Safety Of Tolterodine Extended Release Capsule Compared With Tolterodine Immediate Release Tablet
NCT00139724 ·Status: COMPLETED ·Phase: PHASE3
-
Clinical Trial of Solifenacin Versus Placebo Plus Pessary for Women With Vaginal Prolapse
NCT01092624 ·Status: TERMINATED ·Phase: PHASE4
-
Clinical Trial to Evaluate the Efficacy and Safety of Fesoterodine in Comparison to Tolterodine Extended Release(ER)in Patients With Overactive Bladder.
NCT00611026 ·Status: COMPLETED ·Phase: PHASE3
-
Vibe First In Human Study for the Assessment of Safety and Initial Performance of the Vibe Delivery System in Subjects With Idiopathic Overactive Bladder
NCT03874780 ·Status: COMPLETED ·Phase: NA
-
OnabotulinumtoxinA Bladder Injection Study
NCT03523091 ·Status: TERMINATED ·Phase: PHASE4
-
InSite for Over Active Bladder
NCT00547378 ·Status: COMPLETED ·Phase: PHASE4
-
A Study to Examine the Safety and Efficacy of a New Drug in Patients With Symptoms of Overactive Bladder (OAB)
NCT03492281 ·Status: COMPLETED ·Phase: PHASE3
-
Composur: Study to Understand the Performance of Vibegron in Participants with Overactive Bladder (OAB)
NCT05067478 ·Status: COMPLETED
-
An Extension Study to Examine the Safety and Tolerability of a New Drug in Patients With Symptoms of Overactive Bladder (OAB).
NCT03583372 ·Status: COMPLETED ·Phase: PHASE3
-
Clinical Trial for the Assessment of Safety, Usability and Efficacy of the Vixe Combination for OAB in Female Subjects
NCT06345677 ·Status: COMPLETED ·Phase: NA